Each cell population (NK cells, CD4+ T cells, and CD8+ T cells) was comprised of a range of 28–44 ME/CFS subjects and 26–39 healthy controls, while each experiment within these cell populations involved 8–20 individuals per condition. The gene discussed is CD8A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.